상세 보기
Phase II trial of lazertinib in patients with epidermal growth factor receptor (EGFR) mutation-positive (M plus ), metastatic non-small cell lung cancer (NSCLC) with asymptomatic or mild symptomatic brain metastases after failure of EGFR tyrosine kinase inhibitor (TKI) (KCSG LU20-15)
- Hong, Min Hee;
- Choi, Yoon Ji;
- Ahn, Hee Kyung;
- Keam, Bhumsuk;
- Kim, Yu Jung;
- 외 3명
Citations
WEB OF SCIENCE
2- 제목
- Phase II trial of lazertinib in patients with epidermal growth factor receptor (EGFR) mutation-positive (M plus ), metastatic non-small cell lung cancer (NSCLC) with asymptomatic or mild symptomatic brain metastases after failure of EGFR tyrosine kinase inhibitor (TKI) (KCSG LU20-15)
- 저자
- Hong, Min Hee; Choi, Yoon Ji; Ahn, Hee Kyung; Keam, Bhumsuk; Kim, Yu Jung; Kim, Ju Won; Kim, Hye Ryun; Kang, Jin-Hyoung
- 발행일
- 2023-06
- 유형
- Meeting Abstract
- 권
- 41
- 호
- 16
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X